Improved endothelial function with metformin in type 2 diabetes mellitus

被引:401
作者
Mather, KJ
Verma, S
Anderson, TJ
机构
[1] Univ Calgary, Fac Med, Div Cardiol, Calgary, AB T2N 2T9, Canada
[2] Indiana Univ, Div Endocrinol & Metab, Indianapolis, IN 46204 USA
[3] Univ Toronto, Div Cardiac Surg, Toronto, ON, Canada
关键词
D O I
10.1016/S0735-1097(01)01129-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study was designed to assess the effect of metformin on impaired endothelial function in type 2 diabetes mellitus. BACKGROUND Abnormalities in vascular endothelial function are well recognized among patients with type 2 (insulin-resistant) diabetes mellitus. Insulin resistance itself may be central to the pathogenesis of endothelial dysfunction. The effects of metformin, an antidiabetic agent that improves insulin sensitivity, on endothelial function have not been reported. METHODS Subjects with diet-treated type 2 diabetes but without the confounding collection of cardiovascular risk factors seen in the metabolic syndrome were treated with metformin 500 mg twice daily (n = 29) or placebo (n = 15) for 12 weeks. Before and after treatment, blood flow responses to intraarterial administration of endothelium-dependent (acetylcholine), endothelium-independent (sodium nitroprusside) and nitrate-independent (verapamil) vasodilators were measured using forearm plethysmography. Whole-body insulin resistance was assessed on both occasions using the homeostasis model (HOMA-IR). RESULTS Subjects who received metformin demonstrated statistically significant improvement in acetylcholine-stimulated flows compared with those treated with placebo (p = 0.0027 by 2-way analysis of variance), whereas no significant effect was seen on nitroprusside-stimulated (p = 0.27) or verapamil-stimulated (p = 0.40) flows. There was a significant improvement in insulin resistance with metformin (32.5% reduction in HOMA-IR, p = 0.01), and by stepwise multivariate analysis insulin resistance was the sole predictor of endothelium-dependent blood how following treatment (r = -0.659, p = 0.0012). CONCLUSIONS Metformin treatment improved both insulin resistance and endothelial function, with a strong statistical link between these variables. This supports the concept of the central role of insulin resistance in the pathogenesis of endothelial dysfunction in type 2 diabetes mellitus. This has important implications for the investigation and treatment of vascular disease in patients with type 2 diabetes mellitus. (J Am Coll Cardiol 2001;37:1344-50) (C) 2001 by the American College of Cardiology.
引用
收藏
页码:1344 / 1350
页数:7
相关论文
共 38 条
[1]   Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin [J].
Abbasi, F ;
Carantoni, M ;
Chen, YDI ;
Reaven, GM .
DIABETES CARE, 1998, 21 (08) :1301-1305
[2]   Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease - The bypass angioplasty revascularization investigation (BARI) [J].
Alderman, E ;
Bourassa, M ;
Brooks, MM ;
Califf, R ;
Chaitman, B ;
Detre, K ;
Faxon, DP ;
Feit, F ;
Frye, RL ;
Hardison, RM ;
Holmes, D ;
Holubkov, R ;
Kouchoukos, N ;
Krone, R ;
Rogers, W ;
Rosen, AD ;
Schaff, H ;
Schwartz, L ;
Siewers, AS ;
Sopko, G ;
SuttonTyrrell, K ;
Whitlow, P .
CIRCULATION, 1997, 96 (06) :1761-1769
[3]   Drug therapy - Metformin [J].
Bailey, CJ ;
Turner, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579
[4]   Vascular effects of metformin - Possible mechanisms for its antihypertensive action in the spontaneously hypertensive rat [J].
Bhalla, RC ;
Toth, KF ;
Tan, EQ ;
Bhatty, RA ;
Mathias, E ;
Sharma, RV .
AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (06) :570-576
[5]   Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity [J].
Bonora, E ;
Saggiani, F ;
Targher, G ;
Zenere, MB ;
Alberiche, M ;
Monauni, T ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2000, 23 (01) :57-63
[6]   Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects -: The BIGPRO1 study [J].
Charles, MA ;
Morange, P ;
Eschwège, E ;
André, P ;
Vague, P ;
Juhan-Vague, I .
DIABETES CARE, 1998, 21 (11) :1967-1972
[7]   Insulin-mediated vasodilation and glucose uptake are functionally linked in humans [J].
Cleland, SJ ;
Petrie, JR ;
Ueda, S ;
Elliott, HL ;
Connell, JMC .
HYPERTENSION, 1999, 33 (01) :554-558
[8]   Effects of metformin on tyrosine kinase activity, glucose transport, and intracellular calcium in rat vascular smooth muscle [J].
Dominguez, LJ ;
Davidoff, AJ ;
Srinivas, PR ;
Standley, PR ;
Walsh, MF ;
Sowers, JR .
ENDOCRINOLOGY, 1996, 137 (01) :113-121
[9]   Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas [J].
Emoto, M ;
Nishizawa, Y ;
Maekawa, K ;
Hiura, Y ;
Kanda, H ;
Kawagishi, T ;
Shoji, T ;
Okuno, Y ;
Morii, H .
DIABETES CARE, 1999, 22 (05) :818-822
[10]   An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats [J].
Faure, P ;
Rossini, E ;
Wiernsperger, N ;
Richard, MJ ;
Favier, A ;
Halimi, S .
DIABETES, 1999, 48 (02) :353-357